Lexicon Pharmaceuticals | LXRX - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Abbott USD 25.51B 488M 2026-03
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Coherus Biosciences USD 133.79M 72.25M 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Illumina USD 2.83B 96M 2026-06
Insmed USD 1.63B 20.75M 2026-06
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
J&J USD 59.77B 601M 2026-06
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
MannKind USD 245.71M 5.45M 2026-06
Merck USD 36.68B 1.66B 2026-06
Moderna USD 5.82B 45M 2026-06
Novartis USD 27.35B 744M 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12